Saturday, July 11, 2026
RSS

Inside BCI

Brain-Computer Interface Industry News
Industry News Research Policy Opinion Market Moves
About Directory Glossary

Tag: Industrial-Builder-posture

11 articles

Policy & Regulation

Beijing Tiantan Hospital seeds Xizang's first plateau BCI centre at Lhasa People's Hospital

Xinhua reported on 9 July 2026 that Xizang (Tibet Autonomous Region)'s first plateau brain-computer interface clinical application centre was inaugurated at Lhasa People's Hospital. A medical assistance team from Beijing Tiantan Hospital, Capital Medical University, introduced the non-invasive EEG-based BCI technology, which drives exoskeleton and robotic-arm actuators for motor rehabilitation. The centre sits within a six-year Tiantan-Lhasa department-support partnership dating to 2020, and targets cerebral haemorrhage, cerebral ischemia, TBI, spinal cord injury, and peripheral nerve injury indications.

Jul 10

Market Moves

CNBC profiles BrainCo as the Hangzhou non-invasive BCI leader runs up to its Hong Kong IPO

CNBC published a video interview by China reporter Elaine Yu with Nyx He, Partner and Senior Vice President at BrainCo, on 10 July 2026. The interview lands six months after BrainCo confidentially filed for a Hong Kong Stock Exchange listing on 12 January 2026 with CICC and UBS Group AG as arrangers, and six months after the company closed a ¥2 billion (approximately US$286 million) financing round co-led by IDG Capital and Walden International on 8 January 2026. BrainCo is one of Hangzhou's Six Little Dragons alongside DeepSeek, Unitree Robotics, Game Science, DEEP Robotics, and Manycore Tech.

Jul 10

Policy & Regulation

Beijing names Changfazhan its first BCI incubation platform under the Future Industry programme

Beijing Municipal Bureau of Economy and Information Technology announced on 1 July 2026, with English release on 7 July, that the Changfazhan Brain Science and Brain-Computer Interface Incubation Platform in Changping district has been designated as one of seven newly recognised Future Industry Incubation Platforms, the first BCI-specific platform under that specific programme. Shanghai municipal science commission director Luo Dajin separately claimed on 6 July that Shanghai hosted nearly 60 per cent of China's BCI financing events, 40 per cent of the disclosed funding amount, and one-third of the country's BCI companies in the first half of 2026.

Jul 7

Policy & Regulation

China's NMPA locks BCI device classification: every implant is Class III, one narrow Class II lane

China's National Medical Products Administration issued Announcement No. 24 (2026) on 29 June 2026, releasing final Guiding Principles for the Classification and Definition of Brain-Computer Interface Medical Device Products plus a companion Generic Naming Guidelines. Every invasive BCI is Class III. Non-invasive BCIs are Class III by default. Non-invasive stroke-motor rehabilitation devices are Class II only if they do not incorporate artificial intelligence.

Jul 4

Market Moves

Gestala closes US$62 million Angel+ round for ultrasound BCI, opens Shanghai NeuroAI headquarters

Gestala (格式塔科技), a Chinese non-invasive ultrasound brain-computer interface company led by founder and CEO Phoenix Peng, announced on 3 July 2026 that it had closed a US$62 million Angel+ financing round and formally opened a Shanghai NeuroAI headquarters. The company is the third Chinese ultrasound BCI startup to disclose funding within ten days, alongside Sisen Technology (1 July 2026) and Huachao Shenkong.

Jul 3

Market Moves

China and South Korea have shipped three BCI industrial-policy launches in eight weeks

Between 1 May and 19 June 2026, three operational state-backed brain-computer interface moves landed across China and South Korea. China State Council Order No. 818 took effect on 1 May 2026, opening a parallel commercial pathway for advanced biomedical technologies that names BCI explicitly. Tianjin formally inaugurated a dedicated BCI industrial cluster with 100 million yuan in annual funding on 29 May 2026. South Korea launched its first national BCI industry association in Seoul on 16 June 2026, anchored to the K-Moonshot strategic R&D mission. Three dated, named, primary-sourced moves in eight weeks across two jurisdictions.

Jun 21

Market Moves

Korea's BCI industry forms a national association in Seoul, anchored to the K-Moonshot state programme

The Korean BCI Association (한국BCI협회) held its inaugural general meeting on Tuesday 16 June 2026 at Centerfield in Gangnam-gu, Seoul. Seoul National University Hospital President Baek Nam-jong was elected inaugural chair. Standing vice president is Kim Yong-jin, who chairs ISO/IEC JTC 1 SC 41 (Internet of Things and Digital Twin). Founding members include Ybrain, Dynamic Solution, Vibatrobotics, Ceragem on the industry side; Seoul National University Hospital, Severance Hospital and Korea University Anam Hospital on the medical side; and KAIST, DGIST, UNIST, Korea University, Catholic Kwandong University, Yonsei University and Hanyang University on the academic side. The association states it will actively support the K-Moonshot strategic R&D programme that launched in March 2026 with 12 missions, including a BCI mission led by Korea University Professor Cho Il-joo.

Jun 19